Table 2.
Theme | Predictor | # times reported (n=78) |
Laboratory test | Blood biochemistry tests (eg, PAPP-A, triglycerides, β-hCG and uric acid) | 16 |
Ultrasonography | 3 | |
Urine dipstick | 2 | |
Blood pressure | 2 | |
Oxygen saturation | 1 | |
Maternal characteristics | Parity | 5 |
Age | 5 | |
Body mass index | 3 | |
Household monthly income | 2 | |
Occupation | 1 | |
Method of contraception | 1 | |
Skin colour | 1 | |
Educational level | 1 | |
Oligomenorrhoea | 1 | |
Comorbidity | 1 | |
Place of residence | 1 | |
Increase of acanthosis nigricans | 1 | |
Family history of diabetes | 1 | |
Weight accrual rate | 1 | |
Previous pregnancy characteristics | Previous adverse pregnancy outcome (eg, PPH, macrosomia, stillbirth, preterm) | 5 |
Interbirth interval | 1 | |
Current pregnancy characteristics | Gestational age | 5 |
Number of antenatal visits | 3 | |
Bleeding | 2 | |
Chest pain/dyspnoea | 2 | |
Cervical glandular area | 1 | |
Umbilical cord complication | 1 | |
Cervical length | 1 | |
Antenatal hospitalisation related to current pregnancy | 1 | |
Labour augmentation | 1 | |
Headache/visual changes | 1 | |
Retained placenta | 1 | |
Length of first and second stage of labour | 1 | |
Neonatal characteristics | Presentation | 1 |
Birth weight | 1 | |
Apgar score | 1 |
hCG, human chorionic gonadotropin; PAPP-A, pregnancy-associated plasma protein A.